
Fast-growing cancer could be slowed by common blood pressure drug, research shows
Fox News
University of Pennsylvania researchers discovered how the decades-old blood pressure drug hydralazine could double as a new glioblastoma treatment.
Khloe Quill is a lifestyle production assistant with Fox News Digital. She and the lifestyle team cover a range of story topics including food and drink, travel, and health.
"It came from a ‘pre-target’ era of drug discovery, when researchers relied on what they saw in patients first and only later tried to explain the biology behind it," Kyosuke Shishikura, a physician-scientist at the University of Pennsylvania who was involved in the study, said in a press release from the university.
More Related News













